David Martínez-Cecilia1,2, Martina Fontana1, Najaf N Siddiqi1, Mark Halls1, Salvatore Barbaro1, Mohammad Abu-Hilal3. 1. Department of Hepato-Biliary and Pancreatic Surgery, University Hospital Southampton, NHS Foundation Trust, Southampton, UK. 2. Hospital Universitario de Toledo, Toledo, Spain. 3. Department of Hepato-Biliary and Pancreatic Surgery, University Hospital Southampton, NHS Foundation Trust, Southampton, UK. abuhilal9@gmail.com.
Abstract
BACKGROUND: Laparoscopic liver resections for lesions in the postero-superior segments are technically demanding due their deep location and relation with the vena cava. However, previous reports have demonstrated the feasibility and safety of these resections in centres with advanced experience in laparoscopic liver surgery. In this case series, we present our results and experience of laparoscopic parenchymal sparing liver resections of lesions in segment 8. METHODS: All patients undergoing laparoscopic liver resections of segment 8 lesions, alone or combined with other liver resections, between August 2003 and July 2016 were included. Analysis of baseline characteristics and perioperative results was performed for the whole cohort. A separate subgroup analysis was performed for isolated segment 8 resections. Long-term results were analyzed in patients with colorectal liver metastases. A video is attached for thorough explanation of surgical technique. RESULTS: A total of 30 patients were included. Among them, 13 patients had isolated segment 8 resections. Operative time for the whole cohort and isolated segment 8 resections were 210 min (range 180-247 min) and 200 min (range 90-300 min), respectively. The conversion rate was 3.4% for the entire cohort and 0 for isolated segment 8 resections. Major morbidity was 7 and 0%, respectively. R0 rates were 96% for the entire cohort and 92% for isolated segment 8 resections. Recurrence free survival in the colorectal liver metastasis subgroup was 82, 71 and 54% at 1, 3 and 5 years. Overall survival was 94, 82 and 65% at 1, 3 and 5 years. CONCLUSIONS: Laparoscopic resection of lesions in segment 8 is feasible and offers the benefits of minimally invasive surgery with parenchyma sparing resections. However, advanced experience in LLR is essential to ensure safety and oncological results.
BACKGROUND: Laparoscopic liver resections for lesions in the postero-superior segments are technically demanding due their deep location and relation with the vena cava. However, previous reports have demonstrated the feasibility and safety of these resections in centres with advanced experience in laparoscopic liver surgery. In this case series, we present our results and experience of laparoscopic parenchymal sparing liver resections of lesions in segment 8. METHODS: All patients undergoing laparoscopic liver resections of segment 8 lesions, alone or combined with other liver resections, between August 2003 and July 2016 were included. Analysis of baseline characteristics and perioperative results was performed for the whole cohort. A separate subgroup analysis was performed for isolated segment 8 resections. Long-term results were analyzed in patients with colorectal liver metastases. A video is attached for thorough explanation of surgical technique. RESULTS: A total of 30 patients were included. Among them, 13 patients had isolated segment 8 resections. Operative time for the whole cohort and isolated segment 8 resections were 210 min (range 180-247 min) and 200 min (range 90-300 min), respectively. The conversion rate was 3.4% for the entire cohort and 0 for isolated segment 8 resections. Major morbidity was 7 and 0%, respectively. R0 rates were 96% for the entire cohort and 92% for isolated segment 8 resections. Recurrence free survival in the colorectal liver metastasis subgroup was 82, 71 and 54% at 1, 3 and 5 years. Overall survival was 94, 82 and 65% at 1, 3 and 5 years. CONCLUSIONS: Laparoscopic resection of lesions in segment 8 is feasible and offers the benefits of minimally invasive surgery with parenchyma sparing resections. However, advanced experience in LLR is essential to ensure safety and oncological results.
Authors: Mark J W McPhail; Tina Scibelli; Mahmoud Abdelaziz; Amin Titi; Neil W Pearce; Mohammed Abu Hilal Journal: Expert Rev Gastroenterol Hepatol Date: 2009-08 Impact factor: 3.869
Authors: F Cipriani; M Rawashdeh; L Stanton; T Armstrong; A Takhar; N W Pearce; J Primrose; M Abu Hilal Journal: Br J Surg Date: 2016-08-03 Impact factor: 6.939
Authors: Federica Cipriani; Vishal G Shelat; Majd Rawashdeh; Elisa Francone; Luca Aldrighetti; Arjun Takhar; Thomas Armstrong; Neil W Pearce; Mohammad Abu Hilal Journal: J Am Coll Surg Date: 2015-03-27 Impact factor: 6.113
Authors: Neil William Pearce; Francesco Di Fabio; Mabel Joey Teng; Shareef Syed; John Neil Primrose; Mohammed Abu Hilal Journal: Am J Surg Date: 2011-08-20 Impact factor: 2.565
Authors: Fernando Rotellar; Fernando Pardo; Alvaro Bueno; Pablo Martí-Cruchaga; Gabriel Zozaya Journal: Langenbecks Arch Surg Date: 2011-12-20 Impact factor: 3.445
Authors: R Santambrogio; E Opocher; A Pisani Ceretti; M Barabino; M Costa; S Leone; M Montorsi Journal: Surg Endosc Date: 2006-11-21 Impact factor: 4.584
Authors: Joseph F Buell; Daniel Cherqui; David A Geller; Nicholas O'Rourke; David Iannitti; Ibrahim Dagher; Alan J Koffron; Mark Thomas; Brice Gayet; Ho Seong Han; Go Wakabayashi; Giulio Belli; Hironori Kaneko; Chen-Guo Ker; Olivier Scatton; Alexis Laurent; Eddie K Abdalla; Prosanto Chaudhury; Erik Dutson; Clark Gamblin; Michael D'Angelica; David Nagorney; Giuliano Testa; Daniel Labow; Derrik Manas; Ronnie T Poon; Heidi Nelson; Robert Martin; Bryan Clary; Wright C Pinson; John Martinie; Jean-Nicolas Vauthey; Robert Goldstein; Sasan Roayaie; David Barlet; Joseph Espat; Michael Abecassis; Myrddin Rees; Yuman Fong; Kelly M McMasters; Christoph Broelsch; Ron Busuttil; Jacques Belghiti; Steven Strasberg; Ravi S Chari Journal: Ann Surg Date: 2009-11 Impact factor: 12.969
Authors: Christoph Kuemmerli; Robert S Fichtinger; Alma Moekotte; Luca A Aldrighetti; Somaiah Aroori; Marc G H Besselink; Mathieu D'Hondt; Rafael Díaz-Nieto; Bjørn Edwin; Mikhail Efanov; Giuseppe M Ettorre; Krishna V Menon; Aali J Sheen; Zahir Soonawalla; Robert Sutcliffe; Roberto I Troisi; Steven A White; Lloyd Brandts; Gerard J P van Breukelen; Jasper Sijberden; Siân A Pugh; Zina Eminton; John N Primrose; Ronald van Dam; Mohammed Abu Hilal Journal: Trials Date: 2022-03-09 Impact factor: 2.279
Authors: Andrew A Gumbs; Eric Lorenz; Tzu-Jung Tsai; Lee Starker; Joe Flanagan; Andrea Benedetti Cacciaguerra; Ng Jing Yu; Melinda Bajul; Elie Chouillard; Roland Croner; Mohammad Abu Hilal Journal: Cancers (Basel) Date: 2022-03-08 Impact factor: 6.639